[Treatment of myopathies and spinal muscular atrophies (author's transl)].
D000690:Amyotrophic Lateral Sclerosis / Q000628:therapy; D001379:Azathioprine / Q000627:therapeutic use; D003095:Collagen Diseases / Q000188:drug therapy; D003882:Dermatomyositis / Q000188:drug therapy; D006012:Glycogen Storage Disease Type V / Q000188:drug therapy; D006801:Humans; D006947:Hyperkalemia / Q000150:complications; D007008:Hypokalemia / Q000150:complications; D007545:Isoproterenol / Q000627:therapeutic use; D009133:Muscular Atrophy / Q000628:therapy; D009135:Muscular Diseases / Q000628:therapy*; D009136:Muscular Dystrophies / Q000188:drug therapy; D009220:Myositis / Q000188:drug therapy; D009468:Neuromuscular Diseases / Q000628:therapy; D026741:Physical Therapy Modalities; D011241:Prednisone / Q000627:therapeutic use
D007545:Isoproterenol; D001379:Azathioprine; D011241:Prednisone
Therapie der Myositiden, Myopathien und spinalen Muskelatrophien.